Sands Capital Ventures, LLC - Q2 2022 holdings

$364 Million is the total value of Sands Capital Ventures, LLC's 19 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 5.6% .

 Value Shares↓ Weighting
PATH  UIPATH INC$69,336,000
-15.7%
3,811,7790.0%19.04%
+10.7%
 DICE THERAPEUTICS, INC.$48,872,000
-18.9%
3,148,9700.0%13.42%
+6.6%
DASH  DOORDASH INC$38,595,000
-45.2%
601,4540.0%10.60%
-28.0%
 NU HOLDINGS LTD.$34,172,000
-51.6%
9,136,8350.0%9.38%
-36.3%
 SAMSARA, INC.$30,296,000
-30.3%
2,712,2560.0%8.32%
-8.4%
SNOW  SNOWFLAKE INC$29,845,000
-39.3%
214,6210.0%8.20%
-20.2%
KRTX SellKARUNA THERAPEUTICS, INC.$21,873,000
-35.6%
172,895
-35.5%
6.01%
-15.4%
TXG New10X Genomics, Inc.$21,800,000481,770
+100.0%
5.99%
 CINCOR PHARMA, INC.$17,898,000
+7.4%
950,0000.0%4.92%
+41.2%
ABOS  ACUMEN PHARMACEUTICALS, INC$16,060,000
+20.2%
3,417,0750.0%4.41%
+58.0%
OLK BuyOLINK HOLDING AB$10,724,000
+42.7%
705,514
+65.8%
2.94%
+87.6%
MASS  908 DEVICES INC$6,721,000
+8.3%
326,4270.0%1.85%
+42.4%
TARS  TARSUS PHARMACEUTICALS INC$3,796,000
-13.2%
260,0000.0%1.04%
+14.0%
RGEN  REPLIGEN CORP.$3,661,000
-13.7%
22,5440.0%1.00%
+13.4%
 SAMSARA, INC.$3,641,000
-30.3%
326,0000.0%1.00%
-8.3%
TSHA  TAYSHA GENE THERAPIES INC$2,697,000
-42.9%
724,8730.0%0.74%
-24.9%
 CANDEL THERAPEUTICS, INC$2,630,000
-36.4%
811,7370.0%0.72%
-16.3%
SPRB  SPRUCE BIOSCIENCES INC$1,369,000
-13.5%
787,0070.0%0.38%
+13.6%
 ABSCI CORP.$192,000
-60.6%
57,8040.0%0.05%
-48.0%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
UIPATH INC9Q3 202330.2%
DOORDASH INC9Q3 202319.6%
SNOWFLAKE INC9Q3 202314.4%
ACUMEN PHARMACEUTICALS, INC9Q3 202310.0%
908 DEVICES INC9Q3 20231.8%
TARSUS PHARMACEUTICALS INC9Q3 20231.4%
TAYSHA GENE THERAPIES INC9Q3 20232.0%
CANDEL THERAPEUTICS, INC9Q3 20231.3%
SPRUCE BIOSCIENCES INC9Q3 20230.7%
ABSCI CORPORATION9Q3 20230.1%

View Sands Capital Ventures, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
SC 13G/A2024-02-13
SC 13G2024-02-13
13F-HR2023-11-14
13F-HR2023-08-15
13F-HR2023-05-12
SC 13G/A2023-02-14
SC 13G/A2023-02-14
13F-HR2023-02-13
13F-HR2022-11-09

View Sands Capital Ventures, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (364179000.0 != 364178000.0)

Export Sands Capital Ventures, LLC's holdings